Medical device and MedTech insights, news, tips and more

FDA Clears New Disposable Fog-Free Articulating 5mm Laparoscope

April 15, 2020

Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope for minimally invasive abdominal and thoracic surgery. The Xenoscope 5mm articulating disposable laparoscope is designed to improve image quality, reduce fog, lower hospital costs, and reduce bio-hazard risk for the patient and staff.

“Disposable laparoscopes can reduce hospital costs and prevent cross-contamination between patients,” said John Langell MD, President, NEOMED, Greater Cleveland. “Disposable scopes can also reduce downtime and waiting, while providing consistent image quality for each use.”

Laparoscopic procedures typically include large, expensive image processing systems (or “towers”) and re-usable surgical scopes that the hospital cleans in between uses. The towers can cost hundreds of thousands of dollars and cleaning the scopes is time consuming, expensive, and imperfect resulting in patient cross-contamination risk.

“Reducing fog on the scope is important too,” continued Dr. Langell. “Most scopes fog during the procedure forcing us to remove the scope, clean it, and reinsert. A combined disposable and fog-free technology can improve image quality and reduce procedural time…both are good for patient care.”

The new articulating Xenoscope includes a disposable 5mm camera on a rigid shaft with a 900 articulating tip with a low-cost compact reusable Xenobox video processor. The video processor allows the image to be displayed on any HD monitor or a hospital’s existing tower system. Clinicians dispose of the Xenoscope after each procedure to reduce patient and staff biohazard risk which ensures the next procedure includes a new non-contaminated endoscope.

View product video here:

“The Xenoscope does not require large up-front capital equipment expenditures,” said Evan Kelso, CEO of Xenocor. “Xenoscopes have sophisticated image processors for consistent image quality but are still easy to use with universal ‘plug-and-play’ functionality. With a single-use instrument, we can help reduce patient and staff contamination risks due to a dirty scope or incorrect processing. Patients win and hospitals win.”

See Full Press Release: FDA Clears New Disposable Fog-Free Articulating 5mm Laparoscope

Written by: Xenocor, Inc. 

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.